Rezultati - Fernando Pastor

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
    Use of Oligonucleotide Aptamer Ligands to Modulate the Function of Immune Receptors

    Use of Oligonucleotide Aptamer Ligands to Modulate the Function of Immune Receptors od Eli Gilboa, James O McNamara, Fernando Pastor

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay

    Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay od Fernando Pastor, Despina S. Kolonias, Paloma H. Giangrande, Eli Gilboa

    Izdano 2010
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers

    Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers od Fernando Pastor, Despina S. Kolonias, James O McNamara, Eli Gilboa

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Aptamer-iRNAs as Therapeutics for Cancer Treatment

    Aptamer-iRNAs as Therapeutics for Cancer Treatment od Mario Martínez Soldevilla, Daniel Meraviglia-Crivelli, Ashwathi P Menon, Fernando Pastor

    Izdano 2018
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Identification of TIM3 2′-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy

    Identification of TIM3 2′-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy od Sandra Hervás‐Stubbs, Mario Martínez Soldevilla, Helena Villanueva, Uxua Mancheño, Maurizio Bendandi, Fernando Pastor

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    In Silico Aptamer Docking Studies: From a Retrospective Validation to a Prospective Case Study'TIM3 Aptamers Binding

    In Silico Aptamer Docking Studies: From a Retrospective Validation to a Prospective Case Study'TIM3 Aptamers Binding od Obdulia Rabal, Fernando Pastor, Helena Villanueva, Mario Martínez Soldevilla, Sandra Hervás‐Stubbs, Julen Oyarzábal

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    RNA-based therapies in liver metabolic diseases

    RNA-based therapies in liver metabolic diseases od Antonio Fontanellas, Pedro Berraondo, F Urigo, Daniel Jericó, Paolo G.V. Martini, Fernando Pastor, Matías A. Ávila

    Izdano 2025
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?

    Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge? od Mayte Sola, Ashwathi Puravankara Menon, Beatriz Moreno, Daniel Meraviglia-Crivelli, Mario Martínez Soldevilla, Fernando Cartón‐García, Fernando Pastor

    Izdano 2020
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice

    Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice od James O McNamara, Despina S. Kolonias, Fernando Pastor, Robert S. Mittler, Lieping Chen, Paloma H. Giangrande, Bruce A. Sullenger, Eli Gilboa

    Izdano 2008
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells

    MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells od Mario Martínez Soldevilla, Helena Villanueva, Noëlia Casares, Juan José Lasarte, Maurizio Bendandi, Susana Inogès, Ascensión López-Díaz de Cerio, Fernando Pastor

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Modulating T Cell Responses by Targeting CD3

    Modulating T Cell Responses by Targeting CD3 od Ashwathi Puravankara Menon, Beatriz Moreno, Daniel Meraviglia-Crivelli, Francesca Nonatelli, Helena Villanueva, Martin Barainka, Angelina Zheleva, Hisse M. van Santen, Fernando Pastor

    Izdano 2023
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    CD28 Aptamers as Powerful Immune Response Modulators

    CD28 Aptamers as Powerful Immune Response Modulators od Fernando Pastor, Mario Martínez Soldevilla, Helena Villanueva, Despina S. Kolonias, Susana Inogès, Ascensión López‐Díaz de Cerio, Romy Kandzia, Victor Klimyuk, Yuri Gleba, Eli Gilboa, Maurizio Bendandi

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity

    ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity od Mario Martínez Soldevilla, Helena Villanueva, Daniel Meraviglia-Crivelli, Ashwathi Puravankara Menon, Marta Ruiz, Javier Cebollero, María Villalba, Beatriz Moreno, Teresa Lozano, Diana Llópiz, Álvaro Pejenaute, Pablo Sarobe, Fernando Pastor

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Clinical Benefit Associated With Idiotypic Vaccination in Patients With Follicular Lymphoma

    Clinical Benefit Associated With Idiotypic Vaccination in Patients With Follicular Lymphoma od Susana Inogès, Mercedes Rodrı́guez-Calvillo, Natalia Zabalegui, Ascensión López-Dı́az de Cerio, Helena Villanueva, Elena Soria, Lilia Suárez, Arancha Rodríguez‐Caballero, Fernando Pastor, Ricardo García‐Muñoz, Carlos Panizo, Javier Pérez‐Calvo, Ignacio Melero, Eduardo P. C. Rocha, Alberto Órfão, Maurizio Bendandi

    Izdano 2006
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

    A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients od Susana Inogès, Sonia Tejada, Ascensión López‐Díaz de Cerio, Jaime Gállego Pérez‐Larraya, J. Espinós, Miguel Á. Idoate, Pablo Domínguez, M. R. Garcia de Eulate, Javier Aristu, Maurizio Bendandi, Fernando Pastor, Marta M. Alonso, Enrique J. Andreu, Felipe Prósper, Ricardo Díez Valle

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma

    Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma od Daniel Tusé, Nora Ku, Maurizio Bendandi, Carlos Becerra, Robert H. Collins, Nyla Langford, Susana Inogés Sancho, Ascensión López-Dı́az de Cerio, Fernando Pastor, Romy Kandzia, Frank Thieme, Franziska Jarczowski, Dieter Krause, Julian K‐C., Shan Pandya, Victor Klimyuk, Yuri Gleba, John E. Butler-Ransohoff

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory

    TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory od Iker Ausejo‐Mauleon, Sara Labiano, Daniel de la Nava, Virginia Laspidea, Marta Zalacain, Lucía Marrodán, Marc García-Moure, Marisol Gonzalez-Húarriz, Irati Hervás-Corpión, Laasya Dhandapani, Silvestre Vicent, María Collantes, Iván Peñuelas, Oren J. Becher, Mariella G. Filbin, Li Jiang, Jenna LaBelle, Carlos A O de Biagi-Junior, Javad Nazarian, Sandra Laternser, Timothy N. Phoenix, Jasper van der Lugt, Mariëtte E.G. Kranendonk, Raoull Hoogendijk, Sabine Mueller, Carlos de Andrea, Ana C. Anderson, Elizabeth Guruceaga, Carl Koschmann, Viveka Nand Yadav, Jaime Gállego Pérez‐Larraya, Ana Patiño‐García, Fernando Pastor, Marta M. Alonso

    Izdano 2023
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: